<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font19 { font-size : 19; } .font21 { font-size : 21; } .font26 { font-size : 26; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font26">the </span>
   <span class="font21">with </span>
   <span class="font19">COVID- </span>
   <span class="font17">patients </span>
   <span class="font15">could </span>
   <span class="font14">for </span>
   <span class="font14">that </span>
   <span class="font14">are </span>
   <span class="font13">disease </span>
   <span class="font13">clinical </span>
   <span class="font12">have </span>
   <span class="font12">which </span>
   <span class="font12">drug </span>
   <span class="font12">this </span>
   <span class="font12">has </span>
   <span class="font12">such </span>
   <span class="font12">severe </span>
   <span class="font12">would </span>
   <span class="font12">adverse </span>
   <span class="font12">been </span>
   <span class="font12">The </span>
   <span class="font12">antiviral </span>
   <span class="font12">its </span>
   <span class="font12">potential </span>
   <span class="font12">viral </span>
   <span class="font11">coronavirus </span>
   <span class="font11">hydroxychloroquine </span>
   <span class="font11">chloroquine </span>
   <span class="font11">reactions </span>
   <span class="font11">treatment </span>
   <span class="font11">diseases </span>
   <span class="font11">from </span>
   <span class="font11">{background </span>
   <span class="font11">revealed </span>
   <span class="font11">was </span>
   <span class="font11">drugs </span>
   <span class="font11">liver </span>
   <span class="font11">should </span>
   <span class="font11">these </span>
   <span class="font11">required </span>
   <span class="font11">therapy </span>
   <span class="font11">but </span>
   <span class="font11">during </span>
   <span class="font11">effects </span>
   <span class="font11">respiratory </span>
   <span class="font11">COVID-. </span>
   <span class="font11">Ribavirin </span>
   <span class="font11">also </span>
   <span class="font11">considered </span>
   <span class="font11">margin </span>
   <span class="font11">recommended </span>
   <span class="font11">were </span>
   <span class="font11">dose </span>
   <span class="font11">{border-style </span>
   <span class="font11">against </span>
   <span class="font11">daily </span>
   <span class="font11">hepatic </span>
   <span class="font11">plasma </span>
   <span class="font11">who </span>
   <span class="font11">can </span>
   <span class="font11">cardiovascular </span>
   <span class="font11">efficacy </span>
   <span class="font11">highly </span>
   <span class="font11">infection </span>
   <span class="font11">lopinavir/ritonavir </span>
   <span class="font11">pneumonia </span>
   <span class="font11">px;} </span>
   <span class="font11">underlying </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">dosage </span>
   <span class="font11">remdesivir </span>
   <span class="font11">results </span>
   <span class="font10">(COVID-) </span>
   <span class="font10">RNA </span>
   <span class="font10">administration </span>
   <span class="font10">management </span>
   <span class="font10">most </span>
   <span class="font10">not </span>
   <span class="font10">agent </span>
   <span class="font10">common </span>
   <span class="font10">promising </span>
   <span class="font10">renal </span>
   <span class="font10">through </span>
   <span class="font10">trial </span>
   <span class="font10">twice </span>
   <span class="font10">Also, </span>
   <span class="font10">especially </span>
   <span class="font10">more </span>
   <span class="font10">symptoms </span>
   <span class="font10">cardiac </span>
   <span class="font10">cases </span>
   <span class="font10">inhibition </span>
   <span class="font10">mechanism </span>
   <span class="font10">recent </span>
   <span class="font10">studies </span>
   <span class="font10">According </span>
   <span class="font10">Chloroquine </span>
   <span class="font10">IFN-Î± </span>
   <span class="font10">Med </span>
   <span class="font10">adjustment </span>
   <span class="font10">agents </span>
   <span class="font10">based </span>
   <span class="font10">cell </span>
   <span class="font10">effect </span>
   <span class="font10">kidney </span>
   <span class="font10">possible </span>
   <span class="font10">their </span>
   <span class="font10">use </span>
   <span class="font10">Patients </span>
   <span class="font10">acute </span>
   <span class="font10">available </span>
   <span class="font10">further </span>
   <span class="font10">half-life </span>
   <span class="font10">infected </span>
   <span class="font10">review </span>
   <span class="font10">ribavirin </span>
   <span class="font10">risk </span>
   <span class="font10">than </span>
   <span class="font10">trials </span>
   <span class="font10">used </span>
   <span class="font10">virus </span>
   <span class="font10">Since </span>
   <span class="font10">about </span>
   <span class="font10">action </span>
   <span class="font10">because </span>
   <span class="font10">disease, </span>
   <span class="font10">elimination </span>
   <span class="font10">first </span>
   <span class="font10">function </span>
   <span class="font10">immune </span>
   <span class="font10">induce </span>
   <span class="font10">infection. </span>
   <span class="font10">lopinavir </span>
   <span class="font10">new </span>
   <span class="font10">pneumonia. </span>
   <span class="font10">protein </span>
   <span class="font10">reduce </span>
   <span class="font10">related </span>
   <span class="font10">study </span>
   <span class="font10">vitamin </span>
   <span class="font10">Results </span>
   <span class="font10">This </span>
   <span class="font10">according </span>
   <span class="font10">cells </span>
   <span class="font10">chest </span>
   <span class="font10">children </span>
   <span class="font10">combination </span>
   <span class="font10">convalescent </span>
   <span class="font10">damage </span>
   <span class="font10">enhance </span>
   <span class="font10">etc. </span>
   <span class="font10">failure, </span>
   <span class="font10">heart </span>
   <span class="font10">lung </span>
   <span class="font10">may </span>
   <span class="font10">metabolism </span>
   <span class="font10">moderate </span>
   <span class="font10">monitoring </span>
   <span class="font10">novel </span>
   <span class="font10">patient </span>
   <span class="font10">pneumonia, </span>
   <span class="font10">safety </span>
   <span class="font10">showed </span>
   <span class="font10">significantly </span>
   <span class="font10">suggested </span>
   <span class="font10">ACE </span>
   <span class="font10">Lopinavir/Ritonavir </span>
   <span class="font10">activity </span>
   <span class="font10">after </span>
   <span class="font10">data </span>
   <span class="font10">failure </span>
   <span class="font10">group </span>
   <span class="font10">had </span>
   <span class="font10">many </span>
   <span class="font10">might </span>
   <span class="font10">organ </span>
   <span class="font10">pharmacokinetic </span>
   <span class="font10">pharmacotherapy </span>
   <span class="font10">predisposing </span>
   <span class="font10">pregnancy </span>
   <span class="font10">px; </span>
   <span class="font10">ritonavir </span>
   <span class="font10">serum </span>
   <span class="font10">some </span>
   <span class="font10">there </span>
   <span class="font10">treatment. </span>
   <span class="font10">{font-family </span>
   <span class="font10">Although </span>
   <span class="font10">Antimicrob </span>
   <span class="font10">But </span>
   <span class="font10">COVID-, </span>
   <span class="font10">CYPA </span>
   <span class="font10">Drug </span>
   <span class="font10">Not </span>
   <span class="font10">Res </span>
   <span class="font10">Umifenovir </span>
   <span class="font10">around </span>
   <span class="font10">associated </span>
   <span class="font10">avoid </span>
   <span class="font10">beneficial </span>
   <span class="font10">cause </span>
   <span class="font10">confirm </span>
   <span class="font10">confirmed </span>
   <span class="font10">critical </span>
   <span class="font10">dermatologic </span>
   <span class="font10">etc.), </span>
   <span class="font10">font-size </span>
   <span class="font10">hours </span>
   <span class="font10">hours. </span>
   <span class="font10">increased </span>
   <span class="font10">iron </span>
   <span class="font10">level </span>
   <span class="font10">mild </span>
   <span class="font10">number </span>
   <span class="font10">seems </span>
   <span class="font10">still </span>
   <span class="font10">systematic </span>
   <span class="font10">therapeutic </span>
   <span class="font10">transmission </span>
   <span class="font10">viruses </span>
   <span class="font10">â€" </span>
   <span class="font10">(about </span>
   <span class="font10">ARDS </span>
   <span class="font10">Administration </span>
   <span class="font10">Agents </span>
   <span class="font10">Another </span>
   <span class="font10">COVID-: </span>
   <span class="font10">Interferon </span>
   <span class="font10">accumulation </span>
   <span class="font10">all </span>
   <span class="font10">alpha </span>
   <span class="font10">angiotensin </span>
   <span class="font10">azithromycin </span>
   <span class="font10">care </span>
   <span class="font10">chronic </span>
   <span class="font10">close </span>
   <span class="font10">conditions </span>
   <span class="font10">contraindicated </span>
   <span class="font10">cytokines </span>
   <span class="font10">days. </span>
   <span class="font10">double; </span>
   <span class="font10">duration </span>
   <span class="font10">elevated </span>
   <span class="font10">every </span>
   <span class="font10">hematologic </span>
   <span class="font10">high </span>
   <span class="font10">important </span>
   <span class="font10">inhibitors </span>
   <span class="font10">injury </span>
   <span class="font10">major </span>
   <span class="font10">option </span>
   <span class="font10">oral </span>
   <span class="font10">over </span>
   <span class="font10">pre-existing </span>
   <span class="font10">prone </span>
   <span class="font10">published </span>
   <span class="font10">required. </span>
   <span class="font10">role </span>
   <span class="font10">septic </span>
   <span class="font10">small </span>
   <span class="font10">spread </span>
   <span class="font10">syndrome </span>
   <span class="font10">they </span>
   <span class="font10">vitro </span>
   <span class="font10">world </span>
   <span class="font10">After </span>
   <span class="font10">China: </span>
   <span class="font10">Chinese </span>
   <span class="font10">Elsevier </span>
   <span class="font10">GFR </span>
   <span class="font10">Hydroxychloroquine </span>
   <span class="font10">Liver </span>
   <span class="font10">Lopinavir/ritonavir </span>
   <span class="font10">Oral </span>
   <span class="font10">Remdesivir </span>
   <span class="font10">Ritonavir </span>
   <span class="font10">So, </span>
   <span class="font10">Table </span>
   <span class="font10">There </span>
   <span class="font10">These </span>
   <span class="font10">Tocilizumab </span>
   <span class="font10">act </span>
   <span class="font10">administered </span>
   <span class="font10">alternative </span>
   <span class="font10">aspects </span>
   <span class="font10">benefits </span>
   <span class="font10">between </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">broad-spectrum </span>
   <span class="font10">daily. </span>
   <span class="font10">days </span>
   <span class="font10">disease. </span>
   <span class="font10">diseases. </span>
   <span class="font10">distress </span>
   <span class="font10">done </span>
   <span class="font10">each </span>
   <span class="font10">enzyme </span>
   <span class="font10">findings </span>
   <span class="font10">form </span>
   <span class="font10">gastrointestinal </span>
   <span class="font10">health </span>
   <span class="font10">higher </span>
   <span class="font10">immunosuppressive </span>
   <span class="font10">information </span>
   <span class="font10">inhibit </span>
   <span class="font10">interactions </span>
   <span class="font10">into </span>
   <span class="font10">just </span>
   <span class="font10">less </span>
   <span class="font10">main </span>
   <span class="font10">management. </span>
   <span class="font10">membrane </span>
   <span class="font10">mg/kg </span>
   <span class="font10">mortality </span>
   <span class="font10">now </span>
   <span class="font10">other </span>
   <span class="font10">patients, </span>
   <span class="font10">patients. </span>
   <span class="font10">patientsâ€™ </span>
   <span class="font10">plus </span>
   <span class="font10">population </span>
   <span class="font10">presentations </span>
   <span class="font10">previous </span>
   <span class="font10">rate </span>
   <span class="font10">recently </span>
   <span class="font10">receptor </span>
   <span class="font10">reduced </span>
   <span class="font10">report </span>
   <span class="font10">severity </span>
   <span class="font10">solid; </span>
   <span class="font10">supportive </span>
   <span class="font10">therapy. </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">Also </span>
   <span class="font10">Aviptadil </span>
   <span class="font10">COVID--induced </span>
   <span class="font10">Cardiovascular </span>
   <span class="font10">Chloroquine/Hydroxychloroquine </span>
   <span class="font10">Dis </span>
   <span class="font10">Dosage </span>
   <span class="font10">ECMO </span>
   <span class="font10">FDA </span>
   <span class="font10">Food </span>
   <span class="font10">Health </span>
   <span class="font10">Infect </span>
   <span class="font10">Its </span>
   <span class="font10">Kidney </span>
   <span class="font10">Lopinavir </span>
   <span class="font10">NSAIDs </span>
   <span class="font10">Pregnancy </span>
   <span class="font10">Previous </span>
   <span class="font10">Rev </span>
   <span class="font10">Severe </span>
   <span class="font10">Wuhan, </span>
   <span class="font10">abnormalities </span>
   <span class="font10">adjustments </span>
   <span class="font10">adult </span>
   <span class="font10">adults </span>
   <span class="font10">alveolar </span>
   <span class="font10">approved </span>
   <span class="font10">bold </span>
   <span class="font10">both </span>
   <span class="font10">caution. </span>
   <span class="font10">centre </span>
   <span class="font10">chloroquine, </span>
   <span class="font10">chloroquine/hydroxychloroquine </span>
   <span class="font10">choice </span>
   <span class="font10">co-administration </span>
   <span class="font10">comparison </span>
   <span class="font10">concern </span>
   <span class="font10">controversial </span>
   <span class="font10">courier; </span>
   <span class="font10">cytokine </span>
   <span class="font10">detected </span>
   <span class="font10">diabetes </span>
   <span class="font10">different </span>
   <span class="font10">effective </span>
   <span class="font10">em; </span>
   <span class="font10">emergency </span>
   <span class="font10">enhancement </span>
   <span class="font10">events </span>
   <span class="font10">excretion </span>
   <span class="font10">fewer </span>
   <span class="font10">group, </span>
   <span class="font10">hepatitis </span>
   <span class="font10">improve </span>
   <span class="font10">infection, </span>
   <span class="font10">inflammatory </span>
   <span class="font10">larger </span>
   <span class="font10">level, </span>
   <span class="font10">mellitus </span>
   <span class="font10">meta-analysis </span>
   <span class="font10">metabolism. </span>
   <span class="font10">multi-organ </span>
   <span class="font10">once </span>
   <span class="font10">one </span>
   <span class="font10">options </span>
   <span class="font10">oxygen </span>
   <span class="font10">pain, </span>
   <span class="font10">peak </span>
   <span class="font10">people </span>
   <span class="font10">pharmacokinetics </span>
   <span class="font10">polymerase </span>
   <span class="font10">pregnant </span>
   <span class="font10">prevent </span>
   <span class="font10">prolonged </span>
   <span class="font10">pt;} </span>
   <span class="font10">publication </span>
   <span class="font10">randomized </span>
   <span class="font10">reactions, </span>
   <span class="font10">received </span>
   <span class="font10">recovery </span>
   <span class="font10">refractory </span>
   <span class="font10">release </span>
   <span class="font10">reported </span>
   <span class="font10">resource </span>
   <span class="font10">route </span>
   <span class="font10">sample </span>
   <span class="font10">second </span>
   <span class="font10">shock </span>
   <span class="font10">solid </span>
   <span class="font10">special </span>
   <span class="font10">suitable </span>
   <span class="font10">teicoplanin </span>
   <span class="font10">therefore </span>
   <span class="font10">time </span>
   <span class="font10">toxicity </span>
   <span class="font10">tract </span>
   <span class="font10">treat </span>
   <span class="font10">undergone </span>
   <span class="font10">viruses. </span>
   <span class="font10">weeks </span>
   <span class="font10">weight </span>
   <span class="font10">women </span>
  </p>
 </body>
</html>
